TABLE 1

Recommended Seasonal Influenza Vaccines for Different Age Groups: United States, 2014–2015 Influenza Season

VaccineTrade NameManufacturerPresentationThimerosal Mercury Content (μg of Hg per 0.5-mL dose)Age Group
Inactivated
 IIV3FluzoneSanofi Pasteur0.25-mL prefilled syringe06–35 mo
0.5-mL prefilled syringe0≥36 mo
0.5-mL vial0≥36 mo
5.0-mL multidose vial25≥6 mo
 IIV3Fluzone IntradermalSanofi Pasteur0.1-mL prefilled microinjection018–64 y
 IIV3Fluzone HDSanofi Pasteur0.5-mL prefilled syringe0≥65 y
 IIV3FluvirinNovartis0.5-mL prefilled syringe≤1.0≥4 y
5.0-mL multidose vial25≥4 y
 IIV3FluarixGlaxoSmithKline0.5-mL prefilled syringe0≥36 mo
 IIV3FluLavalID Biomedical Corporation of Quebec (distributed by GlaxoSmithKline)5.0-mL multidose vial25≥36 mo
 IIV3AfluriabioCSL0.5-mL prefilled syringe0≥9 ya
5-mL multidose vial24.5≥9 ya
 ccIIV3FlucelvaxNovartis Vaccines0.5-mL prefilled syringe0≥18 y
 IIV4Fluzone QuadrivalentSanofi Pasteur0.25-mL prefilled syringe06–35 mo
0.5-mL prefilled syringe0≥36 mo
0.5-mL vial0≥36 mo
 IIV4Fluarix QuadrivalentGlaxoSmithKline0.5-mL prefilled syringe0≥36 mo
 IIV4FluLaval QuadrivalentID Biomedical Corporation of Quebec (distributed by GlaxoSmithKline)5.0-mL multidose vial25≥36 mo
Recombinant
 RIV3FluBlokProtein Sciences0.5-mL vial018–49y
Live attenuated
 LAIV4FluMist QuadrivalentMedImmune0.2-mL sprayer02–49 y
  • Sources: American Academy of Pediatrics, Committee on Infectious Diseases. Recommendations for prevention and control of influenza in children, 2013–2014. Pediatrics. 2013;132(4):e1089–e1104; and Centers for Disease Control and Prevention. Prevention and control of seasonal influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP)—United States, 2014–2015 influenza season. MMWR Recomm Rep. 2014;63(32):691–697.

  • a Age indication per package insert is ≥5 y; however, the Advisory Committee on Immunization Practices recommends Afluria not be used in children 6 mo through 8 y of age because of febrile reactions reported in this age group. If no other age-appropriate, licensed inactivated seasonal influenza vaccine is available for a child 5 through 8 y of age who has a medical condition that increases the child’s risk of influenza complications, Afluria can be used; however, pediatricians should discuss with the parents or caregivers the benefits and risks of influenza vaccination with Afluria before administering this vaccine.